101 related articles for article (PubMed ID: 9718028)
1. Activated protein C resistance: the commonest hereditary hypercoagulation disorder.
Khogali I; Summerfield GP; Mudawi A
Br J Surg; 1998 Aug; 85(8):1160; author reply 1161. PubMed ID: 9718028
[No Abstract] [Full Text] [Related]
2. Activated protein C resistance: the commonest hereditary hypercoagulation disorder.
Sulaiman-Shoab S
Br J Surg; 1998 Aug; 85(8):1161. PubMed ID: 9718029
[No Abstract] [Full Text] [Related]
3. Activated protein C resistance: the commonest hereditary hypercoagulation disorder.
Schuster KL; Jentschura D
Br J Surg; 1997 Dec; 84(12):1633-5. PubMed ID: 9448606
[No Abstract] [Full Text] [Related]
4. Resistance to activated protein C: a major cause of inherited thrombophilia.
Jensen R; Ens GE
Clin Lab Sci; 1997; 10(4):219-22. PubMed ID: 10169621
[TBL] [Abstract][Full Text] [Related]
5. [A newly discovered blood coagulation disorder. Resistance to activated protein C as a cause of thrombosis].
Dahlbäck B; Svensson PJ
Lakartidningen; 1994 Jan; 91(1-2):50-3. PubMed ID: 8289554
[No Abstract] [Full Text] [Related]
6. [Activated protein C resistance and mutation of coagulation factor V].
Samama MM
Arch Mal Coeur Vaiss; 1996 Jun; 89(6):669-70. PubMed ID: 8760650
[No Abstract] [Full Text] [Related]
7. Activated protein C resistance as a "new" cause of deep venous thrombosis in aviators.
Emonson DL
Aviat Space Environ Med; 1997 Jul; 68(7):606-8. PubMed ID: 9215466
[TBL] [Abstract][Full Text] [Related]
8. [Resistance to activated protein C. A common genetic risk factor in venous thrombosis].
Berntorp E; Svensson P; Zöller B; Lethagen S; Dahlbäck B
Lakartidningen; 1995 Sep; 92(39):3587-90. PubMed ID: 7564599
[No Abstract] [Full Text] [Related]
9. Testing for resistance to activated protein C factor V R506Q.
Mack R; Albanese E; Fernandes H
Arch Pathol Lab Med; 1998 Dec; 122(12):1046. PubMed ID: 9870848
[No Abstract] [Full Text] [Related]
10. Further evidence that activated protein C resistance affects protein C coagulant activity assays.
Jennings I; Kitchen S; Cooper PC; Rimmer JE; Woods TA; Preston FE
Thromb Haemost; 2000 Jan; 83(1):171-2. PubMed ID: 10669173
[No Abstract] [Full Text] [Related]
11. Activated protein C resistance: What have we learned now that the dust has settled?
Petäjä JM; Griffin JH
Ann Med; 1997 Dec; 29(6):469-72. PubMed ID: 9562511
[TBL] [Abstract][Full Text] [Related]
12. Resistance to activated protein C: a new etiology for hypercoagulable states.
Yossepowitch O; Safadi R; Chajek-Shaul T
Isr J Med Sci; 1995 Aug; 31(8):510-2. PubMed ID: 7635704
[No Abstract] [Full Text] [Related]
13. [Recurrent venous thrombosis in 2 Hungarian protein C-deficient families].
Domján G; Gruber A; Blaskó G; Petö I; Sas G
Orv Hetil; 1985 Dec; 126(52):3191-3. PubMed ID: 2934677
[No Abstract] [Full Text] [Related]
14. Coagulation factor V gene mutation associated with activated protein C resistance leading to recurrent thrombosis, leg ulcers, and lymphedema: successful treatment with intermittent compression.
Peus D; von Schmiedeberg S; Pier A; Scharf RE; Wehmeier A; Ruzicka T; Krutmann J
J Am Acad Dermatol; 1996 Aug; 35(2 Pt 2):306-9. PubMed ID: 8698912
[TBL] [Abstract][Full Text] [Related]
15. Strikes in French public transport and resistance to activated protein C.
Eschwège V; Robert A
Lancet; 1996 Jan; 347(8995):206. PubMed ID: 8544587
[No Abstract] [Full Text] [Related]
16. Resistance to activated protein C: a common anticoagulant deficiency in patients with venous leg ulceration.
Peus D; Pittelkow MR
Br J Dermatol; 1997 Aug; 137(2):322-3. PubMed ID: 9292102
[No Abstract] [Full Text] [Related]
17. Report on the diagnosis and treatment of homozygous protein C deficiency. Report of the Working Party on Homozygous Protein C Deficiency of the ICTH-Subcommittee on Protein C and Protein S.
Marlar RA; Montgomery RR; Broekmans AW
Thromb Haemost; 1989 Jun; 61(3):529-31. PubMed ID: 2529664
[No Abstract] [Full Text] [Related]
18. [Changes in hemostasis system in patients with hereditary thrombophilia caused by mutation of blood coagulation factor V ( factor V Leiden)].
Papaian LP; Kobilianskaia VA; Sheĭdina AM; Baranovskaia SS; Sirotkina OV; Kargin VD; Saltykova NB; Beliazo OE; Golovina OG; Papaian KA; Tarkovskaia LR
Ter Arkh; 2001; 73(7):47-51. PubMed ID: 11523408
[TBL] [Abstract][Full Text] [Related]
19. Prevalence of factor V Leiden mutation and other hereditary thrombophilic factors in Egyptian children with portal vein thrombosis: results of a single-center case-control study.
El-Karaksy H; El-Koofy N; El-Hawary M; Mostafa A; Aziz M; El-Shabrawi M; Mohsen NA; Kotb M; El-Raziky M; El-Sonoon MA; A-Kader H
Ann Hematol; 2004 Nov; 83(11):712-5. PubMed ID: 15309526
[TBL] [Abstract][Full Text] [Related]
20. [Venous thrombosis in a pregnant woman heterozygous for factor V Q506 mutation].
Chabane MH; Alhenc-Gelas M; Pathier D; Siguret V; Andreux JP; Gaussem P
Ann Biol Clin (Paris); 1998; 56(1):112-3. PubMed ID: 9754234
[No Abstract] [Full Text] [Related]
[Next] [New Search]
